The Filing Desk

Ducommun

DCO · NYSE · Industrials · Financials, fiscal 2016 to 2025

DCO · Last close · November 19, 2026
$139.21
Value Ducommun yourself

Ducommun's revenue rose 4.9% to $825 million in fiscal 2025. Its operating margin was −4.3%, down from 5.4% a year earlier. Free cash flow was −$49 million, against $20 million a year earlier. The diluted share count fell 0.5%.

DUCOMMUN INCORPORATED Latest fiscal year ended December 31, 2025 10-K filed February 26, 2026 · 0001628280-26-011952 Updated
Revenue
$825M
4.9%
Operating margin
−4.3%
9.7 pts
Net income
−$37M
$22M a year earlier
Free cash flow
−$49M
$20M a year earlier
Return on capital
−3.1%
7.1 pts
Market cap
$2.2B
Nov 19 close
P/E
40.5x
On $3.44 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

About these figures. Net debt to EBITDA for fiscal 2025 is blank: the 10-K's structured data doesn't include every figure it needs.

Charts show fiscal years, from the 10-K filings.

What Ducommun does

Ducommun makes electronic and structural products for aerospace and defense and for industrial customers. It says it offers engineering and manufacturing solutions, from prototype development to complex assemblies.

It has two reportable segments. Electronic Systems designs and makes high-reliability electronic and electromechanical products. Structural Systems designs and makes complex contoured aerostructures and other structures. Its history goes back to a business founded in California in 1849.

Acquisitions are an important part of its growth strategy. In April 2023 it bought BLR Aerospace, a maker of aerodynamic systems for helicopters and airplanes, and added it to Structural Systems.

It also has a production facility in Guaymas, Mexico, and says further consolidation in the aerospace industry could affect it.

Its biggest risks, as it describes them

  • Debt that could limit its financing options and its ability to meet its obligations.
  • Credit facility covenants that restrict its operating and financial flexibility.
  • Depending on a select base of industries and customers.
  • Much of its business depends on U.S. government defense spending.
  • Tariffs, export controls and supply problems for raw materials and equipment.
From Ducommun's annual report on Form 10-K, filed February 26, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2016 to 2024, earnings per share fell 5.4% a year and net income 1.9% a year, as new shares raised the share count by 33% and diluted each share's earnings. Ducommun then lost money in fiscal 2025.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments7646433745
Debt incl. finance leases281242258232300
Net debt (negative means net cash)205196215195255
Net debt to EBITDA2.6x2.8x3.5x2.6x—
Debt to equity0.6x0.5x0.4x0.3x0.5x
Interest coverage4.8x3.6x1.5x3.0x−3.2x
Current ratio3.0x2.6x3.0x3.2x3.5x
Quick ratio2.1x1.8x1.9x2.1x2.5x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Ducommun's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

Insider trades

Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought Ducommun shares on the open market, and 6 insiders sold $7.6 million.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Aug 18, 2026Stephen G OswaldChairman, President & CEO, DirectorSold2,500$203.95$509,875Form 4
Aug 12, 2026Stephen G OswaldChairman, President & CEO, DirectorSold5,766$201.15$1.2 millionForm 4
May 28, 2026Laureen S. GonzalezV.p., CHROSold589$151.99$89,522Form 4
May 20, 2026Rajiv A. TataV.p., G.C. & Corp. SecretarySold1,612$145.00$233,740Form 4
May 20, 2026Suman B. MookerjiSr. V.P., C.f.o.Sold1,514$145.00$219,530Form 4
May 14, 2026Jerry L RedondoS.v.p., Elec. & Struc. SystemsSold5,682$154.36$877,074Form 4
Mar 10, 2026Richard A BaldridgeDirectorSold10,440$130.83$1.4 millionForm 4
Mar 10, 2026Suman B. MookerjiS.v.p., CFOSold7,791$131.90$1.0 millionForm 4
Mar 4, 2026Suman B. MookerjiSr. V.P., C.f.o.Sold14,709$134.21$2.0 millionForm 4
Dec 10, 2025Jerry L RedondoS.v.p., Elec. & Struc. SystemsSold2,000$92.86$185,720Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score7 of 97 of 95 of 9
Rule of 407.8%6.4%−1.0%
Altman Z''4.925.424.71
Accruals ratio−1.4%−1.1%−0.3%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassPassFail
Cash from operations is positivePassPassFail
Return on assets roseFailPassFail
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsPassPassFail
Current ratio rosePassPassPass
Share count didn't riseFailFailPass
Gross margin rosePassPassPass
Revenue rose relative to assetsPassFailPass
F-score7 of 97 of 95 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put Ducommun side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
DucommunFY254.9%−4.3%−5.9%−3.1%—5
AstronicsFY258.4%8.9%5.0%16.1%3.2x7Compare
VSEFY2541.5%8.1%0.5%4.5%1.7x6Compare
Cadre HoldingsFY257.5%11.0%9.3%10.4%2.2x5Compare
Rocket LabFY2538.0%−38.0%−53.5%−30.2%—6Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue551558629721629645712757786825
Revenue growth−17.3%1.4%12.7%14.6%−12.8%2.6%10.4%6.2%3.9%4.9%
Gross profit106103123152138142144163197222
Research and development——————————
Operating income291624564649402942−36
Net income252093229136291622−37
Diluted EPS (US$)2.241.740.772.752.4511.062.331.141.44−2.50
Diluted shares (millions)11121212121212141515
Cash flow
Cash from operations4335465113−1333134−33
Capital expenditure17281818121720201415
Free cash flow26829330−17131220−49
Dividends paid0000000000
Share buybacks0000000000
Acquisitions0600000011400
Stock-based compensation355791111152728
Balance sheet at fiscal year end
Cash and short-term investments721040567646433745
Debt incl. finance leases167216229302314281242258232300
Total assets5155676457908379791,0221,1211,1261,186
Total liabilities303331388498508504496485446525
Shareholders' equity212236257293329475526636680662
Margins and ratios
Gross margin19.4%18.5%19.5%21.1%21.9%22.1%20.2%21.6%25.1%26.9%
Operating margin5.3%2.8%3.8%7.8%7.2%7.6%5.6%3.8%5.4%−4.3%
Net margin4.6%3.6%1.4%4.5%4.6%21.0%4.0%2.1%2.8%−4.5%
Free cash flow margin4.8%1.4%4.5%4.5%0.0%−2.7%1.8%1.5%2.5%−5.9%
Rule of 40 (growth + FCF margin)−12.6%2.8%17.3%19.1%−12.8%−0.1%12.2%7.8%6.4%−1.0%
Return on capital4.9%3.8%4.5%9.4%7.3%6.1%4.9%3.6%3.9%−3.1%
Return on equity12.7%9.0%3.7%11.8%9.4%33.7%5.8%2.7%3.3%−5.6%
Return on assets4.7%3.7%1.5%4.5%3.6%14.9%2.9%1.5%1.9%−3.2%
Net debt to EBITDA3.1x5.6x4.4x3.1x3.5x2.6x2.8x3.5x2.6x—
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Ducommun's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Ducommun.